GO
Loading...

Health Care Providers and Services

More

  • Early Glance: Managed Care companies Wednesday, 18 Mar 2015 | 11:37 AM ET

    Cigna Corp. rose$. 03 or percent, to $124.88. Humana Inc. rose$. 18 or. 1 percent, to $174.18. UnitedHealth Group fell$. 74 or. 6 percent, to $116.86.

  • WASHINGTON, March 11- The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health Corp told Reuters. CVS is one of the largest U.S. pharmacy benefit managers and, along with rival Express Scripts, has put...

  • March 5- Mallinckrodt Plc said it would buy privately held Ikaria Inc, a maker of a respiratory drug and its delivery system, for $2.3 billion to expand its reach in hospitals. Shares of Mallinckrodt, a seller of generics, specialty drugs and medical imaging agents, were up 5 percent at $122 in premarket trading. Mallinckrodt expects the acquisition to add at least...

  • LOS ANGELES, March 4- A second top Los Angeles hospital has reported an outbreak of drug-resistant "superbug" infections, and dozens more potential exposures, from procedures performed with a fiber-optic instrument called a duodenoscope. The Cedars-Sinai cases, like the larger number of infections and potential exposures reported last month at the UCLA...

  • NEW YORK, March 4- U.S. hospital executives said on Wednesday they were optimistic they will avoid the toughest consequences of a Supreme Court decision on whether millions of Americans can continue to purchase subsidized health benefits under Obamacare. "I am hopeful that the court will recognize and uphold the intent of Congress, which was to expand coverage...

  • NEW YORK, March 4- Options on U.S. hospital companies were unusually active on Wednesday, with bets leaning to the bullish side as the U.S. Supreme Court heard arguments on a major challenge to President Barack Obama's healthcare law. Shares of major hospital operators rose as investors interpreted comments made by Supreme Court justices during arguments as...

  • The scopes were linked to the exposure of 179 patients to drug-resistant bacteria at UCLA's Ronald Reagan Medical Center in Los Angeles and may have contributed to two deaths. In early 2014, following a superbug outbreak at a hospital in Illinois, the FDA asked Fujifilm Holdings Corp, Olympus Corp and Pentax, which make the devices, to submit their test results...

  • Private equity tops a list of potential investors in a sector that represents 10 percent of Brazil's gross domestic product and shows promise of growth but is hobbled by aging infrastructure, a dearth of qualified staff and rising costs. Two of those sources said a proposal by Carlyle Group LP to pay as much as 2 billion reais for a 30 percent stake in Rede D'Or...

  • Feb 23- Tenet Healthcare Corp on Monday posted a fourth-quarter net profit compared with a year-ago loss as more patients visited its hospitals due to an improving economy and the expansion of health coverage to more Americans. U.S. hospitals are benefiting from the extension of insurance coverage under the Affordable Care Act through government-run...

  • Feb 23- Humana Inc said on Monday that the U.S. government's proposed payments to insurers that sell Medicare Advantage health plans would mean a 1.25 percent to 1.75 percent cut for the managed care company in 2016.. That is a steeper drop than the 0.95 percent figure the government proposed for the industry on Friday, but was still within expectations, analysts...

  • More than 170 patients who may have been infected by the carbapenem-resistant Enterobacteriaceae, or CRE, are being offered home testing kits that would be analyzed by the University of California at Los Angeles hospital system, UCLA officials said. The UCLA hospital system said an internal investigation determined in late January that CRE may have been...

  • The 179 patients who may have been infected by the carbapenem-resistant Enterobacteriaceae are being offered home testing kits that would be analyzed by the University of California, Los Angeles, hospital system, UCLA officials said. "The two scopes involved with the infection were immediately removed, and UCLA is now utilizing a decontamination process...

  • UCLA is offering those patients free home testing kits that it will later analyze. UCLA said the bacteria might have spread during procedures that used a specialized endoscope inserted down the throat to diagnose and treat pancreas and bile duct diseases. The Los Angeles Times reported that the outbreak occurred at UCLA's Ronald Reagan Medical Center.

  • Feb 11- Drugstore operator Rite Aid Corp agreed to buy pharmacy benefit manager EnvisionRx for about $2 billion, looking to cut drug procurement costs as reimbursement rates fall. Rite Aid's deal comes nearly a decade after larger rival CVS Health Corp bought Caremark Rx for $21 billion, the only other example of a drug chain buying a benefits manager.

  • NEW DELHI, Feb 12- Two state-of-the-art public hospitals in New Delhi are barely operational years after they officially opened- not for lack of funding but because officials did not spend the millions of dollars allocated to treat heart and kidney patients. At the 300- bed Janakpuri Super Speciality Hospital, gleaming marble-floored corridors disappear...

  • After stroke, clot removal saves brain function - studies Wednesday, 11 Feb 2015 | 12:00 PM ET

    The two studies used devices made by Covidien, which was acquired by Medtronic PLC last month and helped pay for one of the trials. Stryker Corp and privately-held Penumbra Inc also manufacture devices approved for clot removal. Patrick Lyden, director of the Stroke Program at Cedars-Sinai Medical Center in Los Angeles, who was not involved in the studies.

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, entering the business of administering health plan benefits. The deal will help Rite Aid compete better with CVS Health Corp, which bought Caremark Rx for $21 billion in 2006.. The acquisition of EnvisionRx will also give Rite Aid access to more...

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, to enter the business of administering drug benefits for employers. The third-largest U.S. drug-store chain said it would pay about $1.8 billion in cash and $200 million in stock. Rite Aid's shares rose 3 percent to $7.88 in premarket trading.

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy privately held pharmacy benefit manager EnvisionRx for about $2 billion.

  • Feb 9- Genworth Financial Inc reported a bigger-than-expected quarterly loss as the U.S. life and mortgage insurer took an after-tax charge of $478 million related to long-term care policies it bought before 1996.. Genworth said it was carrying out a restructuring plan targeting more than $100 million in pre-tax cash savings over the next two years.